322 related articles for article (PubMed ID: 11586955)
1. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.
Dishy V; Sofowora GG; Xie HG; Kim RB; Byrne DW; Stein CM; Wood AJ
N Engl J Med; 2001 Oct; 345(14):1030-5. PubMed ID: 11586955
[TBL] [Abstract][Full Text] [Related]
2. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.
Bruck H; Leineweber K; Park J; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2005 Sep; 78(3):232-8. PubMed ID: 16153394
[TBL] [Abstract][Full Text] [Related]
3. Interaction between beta2 adrenergic receptor polymorphisms determines the extent of isoproterenol-induced vasodilatation ex vivo.
Khalaila JM; Elami A; Caraco Y
Pharmacogenet Genomics; 2007 Oct; 17(10):803-11. PubMed ID: 17885618
[TBL] [Abstract][Full Text] [Related]
4. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
Turnes J; Hernández-Guerra M; Abraldes JG; Bellot P; Oliva R; García-Pagán JC; Bosch J
Hepatology; 2006 Jan; 43(1):34-41. PubMed ID: 16374847
[TBL] [Abstract][Full Text] [Related]
5. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.
Landau R; Morales MA; Antonarakis SE; Blouin JL; Smiley RM
Clin Pharmacol Ther; 2005 Dec; 78(6):656-63. PubMed ID: 16338281
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.
Isaza C; Henao J; Ramirez E; Cuesta F; Cacabelos R
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):237-44. PubMed ID: 16082424
[TBL] [Abstract][Full Text] [Related]
7. The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise.
Eisenach JH; McGuire AM; Schwingler RM; Turner ST; Joyner MJ
Physiol Genomics; 2004 Feb; 16(3):323-8. PubMed ID: 14665698
[TBL] [Abstract][Full Text] [Related]
8. beta2-Adrenoceptor gene variation and systemic vasodilatation during ganglionic blockade.
Hesse C; Schroeder DR; Nicholson WT; Hart EC; Curry TB; Penheiter AR; Turner ST; Joyner MJ; Eisenach JH
J Physiol; 2010 Jul; 588(Pt 14):2669-78. PubMed ID: 20519311
[TBL] [Abstract][Full Text] [Related]
9. Genotype-dependent time course of lymphocyte beta 2-adrenergic receptor down-regulation.
Bruck H; Leineweber K; Beilfuss A; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2003 Sep; 74(3):255-63. PubMed ID: 12966369
[TBL] [Abstract][Full Text] [Related]
10. Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27.
Lee DK; Bates CE; Lipworth BJ
Br J Clin Pharmacol; 2004 Jan; 57(1):100-4. PubMed ID: 14678347
[TBL] [Abstract][Full Text] [Related]
11. beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians.
Gratze G; Fortin J; Labugger R; Binder A; Kotanko P; Timmermann B; Luft FC; Hoehe MR; Skrabal F
Hypertension; 1999 Jun; 33(6):1425-30. PubMed ID: 10373227
[TBL] [Abstract][Full Text] [Related]
12. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
[TBL] [Abstract][Full Text] [Related]
13. Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans.
Cockcroft JR; Gazis AG; Cross DJ; Wheatley A; Dewar J; Hall IP; Noon JP
Hypertension; 2000 Sep; 36(3):371-5. PubMed ID: 10988267
[TBL] [Abstract][Full Text] [Related]
14. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
[TBL] [Abstract][Full Text] [Related]
15. Genotype related differences in beta2 adrenergic receptor density and cardiac function.
Snyder EM; Hulsebus ML; Turner ST; Joyner MJ; Johnson BD
Med Sci Sports Exerc; 2006 May; 38(5):882-6. PubMed ID: 16672841
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
Schindler C; Dobrev D; Grossmann M; Francke K; Pittrow D; Kirch W
Clin Pharmacol Ther; 2004 Jan; 75(1):49-59. PubMed ID: 14749691
[TBL] [Abstract][Full Text] [Related]
17. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
[TBL] [Abstract][Full Text] [Related]
18. Beta2-adrenoceptor Thr164Ile polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo.
Dishy V; Landau R; Sofowora GG; Xie HG; Smiley RM; Kim RB; Byrne DW; Wood AJ; Stein CM
Pharmacogenetics; 2004 Aug; 14(8):517-22. PubMed ID: 15284533
[TBL] [Abstract][Full Text] [Related]
19. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
[TBL] [Abstract][Full Text] [Related]
20. Human response to alpha2-adrenergic agonist stimulation studied in an isolated vascular bed in vivo: Biphasic influence of dose, age, gender, and receptor genotype.
King D; Etzel JP; Chopra S; Smith J; Cadman PE; Rao F; Funk SD; Rana BK; Schork NJ; Insel PA; O'Connor DT
Clin Pharmacol Ther; 2005 May; 77(5):388-403. PubMed ID: 15900285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
